HIFU Update: EDAP Submits U.S. FDA Pre-Market Approval Application for Ablatherm(R)-HIFU for Treatment of Low Risk, Localized Prostate Cancer

LYON, France, Feb. 1, 2013 (GLOBE NEWSWIRE) — EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the submission of its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) on January 31, 2013 for the Company’s Ablatherm-HIFU (High Intensity Focused Ultrasound) for treatment of low risk, localized prostate [...]

Feb 4, 2013 | Posted by in Blog | 0 comments

Northern Westchester Hospital’s Clinical Trials Program Examines the Role of Nutrition in Prostate Cancer Progression

Finally, a Study on the Effects of Diet on the Progression of Prostate Cancer, by Dr. Josh Fink. Dr. Weinberg is one of the experts helping to conduct this study. It would be a huge step forward if, one day, Doctors could tell a man that what he eats directly impacts the progression of his [...]

Jan 31, 2013 | Posted by in Blog | 0 comments

Botox – A New Treatment for Incontinence in Women

McKnight’s Feature Published in The New England Journal of Medicine Botox and oral meds equally effective in treating incontinence in women, study says Botox injections and oral medications both work well in reducing urinary incontinence in women, though Botox is more likely to completely resolve symptoms, a recent study showed. Researchers at Loyola University, Chicago, [...]

Nov 8, 2012 | Posted by in Blog | 0 comments

Your Prostate Cancer Treatment Options

By Peter Jaret WebMD Feature Reviewed by Brunilda Nazario, MD The outlook for men diagnosed with prostate cancer has never been brighter. Doctors now have a variety of ways to treat prostate cancer, including surgery, radiation, and drugs that slow the growth of cancer cells. Both the safety and effectiveness of prostate cancer treatments has [...]

Sep 24, 2012 | Posted by in Blog | 0 comments

PSA Testing Linked to Improved Prostate Cancer Survival

THURSDAY, Aug. 23 (HealthDay News) — Prostate cancer survival rates in the United States have improved since the introduction of prostate-specific antigen (PSA) testing, researchers report. PSA is a protein released into the body by the prostate gland. PSA screening involves measuring the amount of PSA in a man’s blood. The higher the PSA level, [...]

Sep 24, 2012 | Posted by in Blog | 0 comments

Drug-PSA Combo May Pinpoint Prostate Cancer

By Michael Smith, North American Correspondent, MedPage Today Published: August 09, 2012 Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner The drugs used to treat benign prostatic hyperplasia (BPH) may also help detect some hard-to-find cases of prostate cancer, researchers [...]

Sep 3, 2012 | Posted by in Blog | 0 comments